Retrospective cohort study assesses serum albumin's role as a prognostic factor for mortality in ATTRwt, indicating its clinical importance.
BACKGROUND: Nutritional status is a recognised prognostic factor across various diseases, with serum albumin commonly used as a surrogate marker. However, its role in wild-type transthyretin cardiac amyloidosis (ATTRwt) remains underexplored. We aimed to assess the prognostic value of serum albumin at diagnosis in patients with ATTRwt. METHODS: Retrospective cohort study of ATTRwt patients included in an institutional registry between 2008 and 2023. Serum albumin was measured at diagnosis. The primary outcome was two-year all-cause mortality. A receiver operating characteristic (ROC) curve was used to identify the optimal albumin cut-off. Patients were stratified accordingly, and survival analysis was performed using Kaplan-Meier curves and Cox regression models adjusted for clinically relevant variables. In multivariable analysis adjusted for age, NT-proBNP, and heart failure at diagnosis, low serum albumin and heart failure remained independently associated with the outcome. CONCLUSION: Lower serum albumin levels were associated with a higher incidence of all-cause mortality in patients with ATTRwt, underscoring the prognostic value of nutritional status in this population.
No takes yet. Share an insight, caveat, or question.
Decotto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: